Supprelin Implant
Product Images NDC 67979-002

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Supprelin (NDC 67979-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Endo Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Preparing The Patient And The Insertion Site (Supprelin La 1)

An instructional diagram showing a human arm bent at the elbow from a side view with arrows indicating directional movement of the forearm upwards and the arm downwards. The image suggests joint motion but does not include text or additional context.*

FDA Label Image

The Implant To Be Removed Should First Be Located By Palpating The Inner Aspect Of The Upper Arm (Supprelin La 10)

An instructional illustration showing a person holding their arm bent at the elbow with one hand supporting the elbow and the other hand touching or inspecting the forearm area. The image likely demonstrates how to position the arm for a subcutaneous implant procedure or application.*

FDA Label Image

Removal: Antiseptic (Supprelin La 11)

An instructional illustration showing a healthcare professional injecting a subcutaneous implant into a patient's inner forearm. The image demonstrates the administration technique for the SUPPRELIN LA implant containing histrelin acetate.*

FDA Label Image

Removal: Anesthetic (Supprelin La 12)

A black-and-white instructional illustration showing the subcutaneous implantation of SUPPRELIN LA (histrelin acetate) implant in the inner arm of a patient. A healthcare professional wearing gloves is preparing to insert the implant under the skin near the elbow crease.*

FDA Label Image

Making The Incision And Removing The Implant (Supprelin La 13)

An instructional illustration showing the subcutaneous administration of SUPPRELIN LA implant. The image depicts a healthcare professional wearing gloves preparing to insert or handle the implant on a patient's inner arm, near the elbow crease.*

FDA Label Image

Gently But Securely Grasp The Implant With The Sterile Mosquito Clamp And Extract The Implant (Supprelin La 14)

An instructional medical illustration showing the subcutaneous injection or implantation procedure into the inner side of a patient's arm, demonstrating the appropriate site and technique for placement of an implant such as SUPPRELIN LA (histrelin acetate).*

FDA Label Image

Removal: Closing The Incision (Supprelin La 15)

An illustration showing a human arm bent at the elbow with a subcutaneous implant site marked on the inner side of the arm. The image likely demonstrates the placement area for a subcutaneous implant such as SUPPRELIN LA (histrelin acetate).*

FDA Label Image

Hydrogel Figure (Supprelin La 16)

An illustration of a subcutaneous implant showing a hydrogel reservoir surrounding the central drug formulation. The diagram highlights the internal structure of the implant designed for delivering the medication.*

FDA Label Image

Structure Of Histrelin (Supprelin La 17)

Chemical structure diagram of histrelin acetate, the active ingredient in SUPPRELIN LA implant 50 mg by Endo USA, Inc.*

FDA Label Image

Mean And Standard Deviation Of Serum Histrelin Concentrations (ng/ml) Results At Each Visit (Supprelin La 18)

A line graph depicting histrelin concentration (ng/mL) over time in months (1, 3, 6, 9, 12) for three groups: All Patients (N=36), Naive (N=20), and Pre-treated (N=16). The graph shows a decline in concentration from Month 1 to Month 6, stabilizing thereafter with slight variations through Month 12. Error bars indicate variability at each time point.*

FDA Label Image

Vial Image (Supprelin La 19)

Label for Supprelin LA (histrelin acetate) 50 mg subcutaneous implant. Packaging instructions note one sterile implant per package, usual dosage every 12 months, storage at 2-8 °C, and protection from light. Manufactured by Endo Pharmaceuticals Inc., Malvern, PA. NDC 67979-002-01.*

FDA Label Image

Insertion: Antiseptic (Supprelin La 2)

An instructional diagram showing the subcutaneous implantation procedure of SUPPRELIN LA (histrelin acetate) 50 mg implant. The image depicts a healthcare professional holding an applicator device near a patient's arm, illustrating the implant's placement beneath the skin.*

FDA Label Image

Carton Image (Supprelin La 20)

Packaging label for Supprelin LA 50 mg subcutaneous implant containing histrelin acetate. The label shows dosage form and strength, instructions to dispense the enclosed Medication Guide, storage conditions, and manufacturer Endo Pharmaceuticals Inc. The label is predominantly yellow with blue text and includes barcode and regulatory information.*

FDA Label Image

Insertion: Anesthetic (Supprelin La 3)

Illustration showing the subcutaneous implantation procedure of the SUPPRELIN LA (histrelin acetate) implant. The image depicts a healthcare professional inserting the implant under the skin of a patient's inner arm using a specialized device.*

FDA Label Image

Insertion Tool (Supprelin La 4)

An illustration showing a gloved hand holding a medical implant device with a needle attached, likely demonstrating the subcutaneous administration or placement of the implant.*

FDA Label Image

Insert The Implant Into The Cannula (Supprelin La 5)

Two black-and-white instructional illustrations showing gloved hands holding a thin, flexible medical implant device. The first image shows the implant being held straight, while the second shows it being bent or flexed, demonstrating its flexibility and handling.*

FDA Label Image

Making The Incision (Supprelin La 6)

An instructional illustration showing a subcutaneous implant procedure on a person's arm. The image depicts a gloved hand positioning or preparing to insert a small implant just beneath the skin near the inner elbow.*

FDA Label Image

Inserting The Implant (Supprelin La 7)

An instructional illustration showing the subcutaneous implantation procedure of a drug implant. The image depicts a healthcare provider inserting an implant under the skin of a patient's inner arm using a needle or applicator device, highlighting the subcutaneous route of administration.*

FDA Label Image

Insertion: Closing The Incision (Supprelin La 8)

An instructional illustration showing a gloved hand administering a subcutaneous implant into a patient's inner forearm using a disposable applicator. The image demonstrates proper placement and technique for insertion of the implant device.*

FDA Label Image

Retracting The Button Causes The Cannula To Withdraw From The Incision (Supprelin La 9)

An illustration showing a human arm with the area above the elbow flexed. The image appears to indicate a site relevant to a subcutaneous implant procedure, consistent with the dosage form of SUPPRELIN LA (histrelin acetate) implant.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.